BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 11840984)

  • 1. Proceedings of the 6th Novo Nordisk Symposium on Treatment of Bleeding and Thrombotic Disorders. Copenhagen, Denmark, May 3-4, 2001.
    Semin Hematol; 2001 Oct; 38(4 Suppl 12):1-50. PubMed ID: 11840984
    [No Abstract]   [Full Text] [Related]  

  • 2. A critical appraisal of the use of recombinant factor VIIa in acquired bleeding conditions.
    Mittal S; Watson HG
    Br J Haematol; 2006 May; 133(4):355-63. PubMed ID: 16643441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant factor VIIa in the treatment of intractable bleeding in vascular surgery.
    Manning BJ; Hynes N; Courtney DF; Sultan S
    Eur J Vasc Endovasc Surg; 2005 Nov; 30(5):525-7. PubMed ID: 16099693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Administration of activated recombinant factor VII (novo seven) for the control of massive bleeding in gynecology].
    Tanchev S; Pandurski F; Georgiev A; Gesheva Iu; Platikanov V; Dinov P
    Akush Ginekol (Sofiia); 2004; 43 Suppl 2():32-5. PubMed ID: 15518274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of recombinant factor VIIa for adjunctive hemorrhage control in trauma and surgical patients.
    Benharash P; Bongard F; Putnam B
    Am Surg; 2005 Sep; 71(9):776-80. PubMed ID: 16468517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of rFVIIa in non-haemophilia bleeding conditions in paediatrics. A systematic review.
    Mathew P
    Thromb Haemost; 2004 Oct; 92(4):738-46. PubMed ID: 15467904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights into the management of bleeding disorders.
    Escolar G
    Drug News Perspect; 2004 May; 17(4):285-8. PubMed ID: 15334177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant factor VIIa in the treatment of bleeding.
    Midathada MV; Mehta P; Waner M; Fink LM
    Am J Clin Pathol; 2004 Jan; 121(1):124-37. PubMed ID: 14750250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant factor VIIa: a general hemostatic agent? Yes.
    Roberts HR
    J Thromb Haemost; 2004 Oct; 2(10):1691-4. PubMed ID: 15456475
    [No Abstract]   [Full Text] [Related]  

  • 10. Recombinant factor VIIa: a general hemostatic agent? Not yet.
    Levi M
    J Thromb Haemost; 2004 Oct; 2(10):1695-7. PubMed ID: 15456476
    [No Abstract]   [Full Text] [Related]  

  • 11. Antidotes to haemorrhage: recombinant factor VIIa.
    Kessler CM
    Best Pract Res Clin Haematol; 2004 Mar; 17(1):183-97. PubMed ID: 15171966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recombinant activated factor VII in uncontrolled hemorrhage].
    Colomina MJ; Altisent C; Guerrero E; Godet C
    Med Clin (Barc); 2005 Feb; 124(4):156. PubMed ID: 15713248
    [No Abstract]   [Full Text] [Related]  

  • 13. Update on Novo Nordisk's clinical trial programme on NovoSeven.
    Dejgaard A
    Blood Coagul Fibrinolysis; 2003 Jun; 14 Suppl 1():S39-41. PubMed ID: 14567535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant-activated coagulation factor VIIa (NovoSeven): current development.
    Weiskopf RB
    Vox Sang; 2007 May; 92(4):281-8. PubMed ID: 17456151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of recombinant activated factor VII in the management of life-threatening coagulopathic bleeding.
    Gibbs N
    Anaesth Intensive Care; 2005 Apr; 33(2):163-4. PubMed ID: 15960396
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of recombinant activated factor VII in patients with severe coagulopathy and bleeding.
    Ho AM; Dion PW; Karmakar MK
    Anesthesiology; 2003 Apr; 98(4):1025-6; author reply 1026-7. PubMed ID: 12657873
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful use of recombinant factor VIIa for treatment of severe postpartum hemorrhage.
    Hamaekers AE; van Mook WN; Offermans JP; Marcus MA
    Am J Crit Care; 2006 Jul; 15(4):399-401. PubMed ID: 16823017
    [No Abstract]   [Full Text] [Related]  

  • 18. "Off-license" use of recombinant activated factor VII.
    Ghorashian S; Hunt BJ
    Blood Rev; 2004 Dec; 18(4):245-59. PubMed ID: 15501553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of recombinant factor VIIa for bleeding in paediatric practice.
    Millar CG; Stringer MD; Sugarman I; Richards M
    Haemophilia; 2005 Mar; 11(2):171-4. PubMed ID: 15810920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of recombinant activated factor VII in massive obstetric haemorrhage.
    Haynes J; Laffan M; Plaat F
    Int J Obstet Anesth; 2007 Jan; 16(1):40-9. PubMed ID: 17126006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.